Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04101188

Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans

Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Delaware

Newark, Delaware, 19716, United States

Location status: Recruiting

Location contact

Shannon L Lennon, PHD

CONTACT

[email protected]

302-831-2798

About this study

Significant public health efforts have been made towards salt reduction but most have met with failure. Dietary factors such high sodium/low potassium diets contribute to the development of cardiovascular diseases (CVDs) such as atherosclerosis and high blood pressure (BP). This is important as CVD is the number one killer in the U.S. While the role of these two nutrients on BP is widely accepted, their impact on the vasculature has received less attention. Endothelial dysfunction, characterized by impaired dilation, is an important non-traditional risk factor for atherosclerosis. Evidence supporting potassium's beneficial role on vascular health remains unclear although it may be more effective in the presence of a high sodium diet. A purported mechanism responsible for sodium-induced vascular dysfunction is overproduction of reactive oxygen species (ROS) resulting in reduced nitric oxide (NO) production/bioavailability. Additionally, high sodium diets have been shown to stiffen the endothelium. This investigation will evaluate the vascular effects of dietary potassium during a high salt diet including its impact on sodium-induced oxidative stress and endothelial cell stiffness.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy
  • normal blood pressure
  • normal resting ECG

Exclusion criteria

  • hypertension
  • history of heart disease
  • diabetes
  • kidney disease
  • obese (BMI ≥30)
  • significant weight changes in the last 6 months
  • use of tobacco products
  • pregnant
  • on a special diet (gluten free; vegan)
  • take any medications for the above conditions
  • endurance trained athletes

Treatment and study plan

Moderate Potassium/Low Sodium Diet

Other

Consumption of 10 days of a diet moderate in potassium and low in sodium.

Moderate Potassium/High Sodium Diet

Other

Consumption of 10 days of a diet moderate in potassium and high in sodium.

High Potassium/High Sodium Diet

Other

Consumption of 10 days of a diet high in potassium and high in sodium.

Primary outcomes

  1. Conduit artery endothelial-dependent dilation

    Time frame: on day 10 of the diet

    The change in flow-mediated dilation (FMD) between the 3 diets as assessed by brachial artery FMD

  2. Microvascular function

    Time frame: on day 10 of the diet

    Cutaneous microvascular dilatory response to local heating assessed by laser Doppler flowmetry coupled with intradermal microdialysis

Secondary outcomes

  1. Ambulatory BP monitoring

    Time frame: on day 7 and 10 of diet

    assessed by 24-hour ambulatory blood pressure

Study contacts

Contact information is provided by the study sponsor or research team.

Shannon L Lennon, PhD

CONTACT

[email protected]

(302)831-2798

Shannon L Lennon, PhD

CONTACT

[email protected]

3028312798

Sponsors and collaborators

Lead sponsor

University of Delaware

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Sep 24, 2019
Registry last updated
Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.